Skip to main content
. 2022 Mar 12;11(6):1571. doi: 10.3390/jcm11061571

Figure 2.

Figure 2

Cumulative incidence of the occurrence of hepatic encephalopathy. Pre, before rifaximin treatment; 3M, after 3 months of rifaximin treatment; 6M, after 6 months of rifaximin treatment; 9M, after 9 months of rifaximin treatment; 12M, after 12 months of rifaximin treatment.